$IDRA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in IDERA PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in IDERA PHARMACEUTICALS, INC.. Get notifications about new insider transactions in IDERA PHARMACEUTICALS, INC. for free.
Page: < prev 1 2 3 4 5 6 ... 8 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 07 2019 | IDRA | IDERA PHARMACEUTIC ... | Lim Bryant David | SVP and General Cou ... | Grant | A | 0.00 | 18,100 | 0 | 22,843 | 4.7 K to 22.8 K (+381.62 %) |
Jan 07 2019 | IDRA | IDERA PHARMACEUTIC ... | MILANO VINCENT | President & CEO | Option Exercise | A | 3.14 | 84,500 | 265,330 | 84,500 | |
Jan 07 2019 | IDRA | IDERA PHARMACEUTIC ... | MILANO VINCENT | President & CEO | Grant | A | 0.00 | 33,750 | 0 | 89,566 | 55.8 K to 89.6 K (+60.47 %) |
Jan 04 2019 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 3.52 | 3,658 | 12,876 | 85,072 | 81.4 K to 85.1 K (+4.49 %) |
Jan 04 2019 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 3.52 | 3,658 | 12,876 | 4,283,870 | 4.3 M to 4.3 M (+0.09 %) |
Jan 04 2019 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 3.52 | 3,658 | 12,876 | 522,563 | 518.9 K to 522.6 K (+0.70 %) |
Jan 03 2019 | IDRA | IDERA PHARMACEUTIC ... | PIEN HOWARD H | Director | Grant | A | 3.52 | 2,929 | 10,310 | 2,929 | 0 to 2.9 K |
Dec 26 2018 | IDRA | IDERA PHARMACEUTIC ... | MILANO VINCENT | President & CEO | Buy | P | 2.93 | 15,000 | 43,923 | 55,816 | 40.8 K to 55.8 K (+36.75 %) |
Dec 26 2018 | IDRA | IDERA PHARMACEUTIC ... | Lim Bryant David | SVP and General Cou ... | Buy | P | 3.05 | 4,000 | 12,200 | 4,743 | 743 to 4.7 K (+538.36 %) |
Dec 20 2018 | IDRA | IDERA PHARMACEUTIC ... | Horobin Joanna | Chief Medical Offic ... | Buy | P | 3.45 | 300 | 1,035 | 2,044 | 1.7 K to 2 K (+17.20 %) |
Dec 20 2018 | IDRA | IDERA PHARMACEUTIC ... | Goldberg Mark Alan | Director | Buy | P | 3.19 | 10,000 | 31,897 | 10,000 | 0 to 10 K |
Dec 20 2018 | IDRA | IDERA PHARMACEUTIC ... | SCHAFER CAROL | Director | Option Exercise | A | 3.12 | 23,000 | 71,760 | 23,000 | |
Dec 20 2018 | IDRA | IDERA PHARMACEUTIC ... | SCHAFER CAROL | Director | Buy | P | 3.33 | 5,000 | 16,671 | 5,000 | 0 to 5 K |
Oct 03 2018 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 8.71 | 2,340 | 20,381 | 81,414 | 79.1 K to 81.4 K (+2.96 %) |
Oct 03 2018 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 8.71 | 2,340 | 20,381 | 4,280,212 | 4.3 M to 4.3 M (+0.05 %) |
Oct 03 2018 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 8.71 | 2,340 | 20,381 | 518,905 | 516.6 K to 518.9 K (+0.45 %) |
Sep 20 2018 | IDRA | IDERA PHARMACEUTIC ... | PIEN HOWARD H | Director | Option Exercise | A | 7.99 | 23,000 | 183,770 | 23,000 | |
Sep 13 2018 | IDRA | IDERA PHARMACEUTIC ... | Lim Bryant David | SVP and General Cou ... | Option Exercise | A | 9.29 | 130,000 | 1,207,700 | 130,000 | |
Aug 17 2018 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | 10% Owner | Sell | S | 6.35 | 15,000 | 95,324 | 0 | 15 K to 0 (-100.00 %) |
Aug 17 2018 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | 10% Owner | Sell | S | 6.29 | 25,000 | 157,358 | 0 | 25 K to 0 (-100.00 %) |
Aug 17 2018 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | 10% Owner | Sell | S | 6.25 | 15,000 | 93,762 | 0 | 15 K to 0 (-100.00 %) |
Aug 17 2018 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | 10% Owner | Sell | S | 5.98 | 20,000 | 119,500 | 0 | 20 K to 0 (-100.00 %) |
Aug 17 2018 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | 10% Owner | Sell | S | 5.88 | 50,000 | 294,190 | 0 | 50 K to 0 (-100.00 %) |
Aug 17 2018 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | 10% Owner | Sell | S | 5.89 | 8,107 | 47,759 | 0 | 8.1 K to 0 (-100.00 %) |
Aug 17 2018 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | 10% Owner | Sell | S | 5.62 | 75,000 | 421,718 | 0 | 75 K to 0 (-100.00 %) |
Aug 17 2018 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | 10% Owner | Sell | S | 5.55 | 91,893 | 510,098 | 0 | 91.9 K to 0 (-100.00 %) |
Aug 15 2018 | IDRA | IDERA PHARMACEUTIC ... | MILANO VINCENT | President & CEO | Option Exercise | A | 7.39 | 65,000 | 480,350 | 65,000 | |
Aug 15 2018 | IDRA | IDERA PHARMACEUTIC ... | Arcudi III Louis J | Chief Financial Off ... | Option Exercise | A | 7.39 | 32,500 | 240,175 | 32,500 | |
Aug 15 2018 | IDRA | IDERA PHARMACEUTIC ... | Fletcher Robert C. | Sr. VP, Bus. Dev. & ... | Option Exercise | A | 7.39 | 32,500 | 240,175 | 32,500 | |
Aug 15 2018 | IDRA | IDERA PHARMACEUTIC ... | Horobin Joanna | Chief Medical Offic ... | Option Exercise | A | 7.39 | 32,500 | 240,175 | 32,500 | |
Aug 15 2018 | IDRA | IDERA PHARMACEUTIC ... | YINGLING JONATHAN MICHAEL | Chief Scientific Of ... | Option Exercise | A | 7.39 | 32,500 | 240,175 | 32,500 | |
Aug 08 2018 | IDRA | IDERA PHARMACEUTIC ... | MILANO VINCENT | President & CEO | Buy | P | 5.51 | 10,000 | 55,100 | 40,816 | 30.8 K to 40.8 K (+32.45 %) |
Aug 08 2018 | IDRA | IDERA PHARMACEUTIC ... | GERAGHTY JAMES A | Director | Buy | P | 5.58 | 10,000 | 55,800 | 65,433 | 55.4 K to 65.4 K (+18.04 %) |
Jul 24 2018 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | 10% Owner | Sell | S | 0.86 | 492,567 | 422,672 | 0 | 492.6 K to 0 (-100.00 %) |
Jul 24 2018 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | 10% Owner | Sell | S | 0.88 | 556,000 | 489,502 | 0 | 556 K to 0 (-100.00 %) |
Jul 24 2018 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | 10% Owner | Sell | S | 0.85 | 1,725,000 | 1,470,390 | 0 | 1.7 M to 0 (-100.00 %) |
Jul 19 2018 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | 10% Owner | Sell | S | 0.99 | 874,505 | 862,524 | 0 | 874.5 K to 0 (-100.00 %) |
Jul 19 2018 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | 10% Owner | Sell | S | 1.01 | 735,771 | 743,644 | 0 | 735.8 K to 0 (-100.00 %) |
Jul 19 2018 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | 10% Owner | Sell | S | 1.05 | 250,500 | 264,052 | 0 | 250.5 K to 0 (-100.00 %) |
Jul 05 2018 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 1.32 | 16,383 | 21,626 | 632,599 | 616.2 K to 632.6 K (+2.66 %) |
Jul 05 2018 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 1.32 | 16,383 | 21,626 | 34,222,983 | 34.2 M to 34.2 M (+0.05 %) |
Jul 05 2018 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 1.32 | 16,383 | 21,626 | 4,132,528 | 4.1 M to 4.1 M (+0.40 %) |
Jul 05 2018 | IDRA | IDERA PHARMACEUTIC ... | GERAGHTY JAMES A | Director | Grant | A | 1.32 | 8,096 | 10,687 | 443,465 | 435.4 K to 443.5 K (+1.86 %) |
Jun 22 2018 | IDRA | IDERA PHARMACEUTIC ... | GERAGHTY JAMES A | Director | Option Exercise | A | 1.53 | 63,000 | 96,390 | 63,000 | |
Jun 22 2018 | IDRA | IDERA PHARMACEUTIC ... | Goldberg Mark Alan | Director | Option Exercise | A | 1.53 | 50,000 | 76,500 | 50,000 | |
Jun 22 2018 | IDRA | IDERA PHARMACEUTIC ... | GOWEN MAXINE | Director | Option Exercise | A | 1.53 | 50,000 | 76,500 | 50,000 | |
Jun 22 2018 | IDRA | IDERA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Option Exercise | A | 1.53 | 50,000 | 76,500 | 50,000 | |
Jun 21 2018 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 1.53 | 100,000 | 153,000 | 100,000 | |
Apr 27 2018 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | 10% Owner | Option Exercise | X | 0.47 | 1,200,000 | 564,000 | 0 | |
Apr 27 2018 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | 10% Owner | Buy | X | 0.00 | 1,200,000 | 0 | 0 | -1,200,000 to 0 (-100.00 %) |
Apr 04 2018 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 1.62 | 13,349 | 21,625 | 616,216 | 602.9 K to 616.2 K (+2.21 %) |
Apr 04 2018 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 1.62 | 13,349 | 21,625 | 34,206,600 | 34.2 M to 34.2 M (+0.04 %) |
Apr 04 2018 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 1.62 | 13,349 | 21,625 | 4,116,145 | 4.1 M to 4.1 M (+0.33 %) |
Mar 15 2018 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 0.47 | 439,036 | 206,347 | 0 | |
Mar 15 2018 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 0.47 | 17,626,445 | 8,284,429 | 0 | |
Mar 15 2018 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 0.47 | 2,250,846 | 1,057,898 | 0 | |
Mar 15 2018 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Buy | M | 0.47 | 439,036 | 206,347 | 602,867 | 163.8 K to 602.9 K (+267.98 %) |
Mar 15 2018 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Buy | M | 0.47 | 17,626,445 | 8,284,429 | 34,193,251 | 16.6 M to 34.2 M (+106.40 %) |
Mar 15 2018 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Buy | M | 0.47 | 2,250,846 | 1,057,898 | 4,102,796 | 1.9 M to 4.1 M (+121.54 %) |
Jan 19 2018 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | 10% Owner | Sell | S | 2.40 | 200,000 | 480,000 | 0 | 200 K to 0 (-100.00 %) |
Jan 05 2018 | IDRA | IDERA PHARMACEUTIC ... | MILANO VINCENT | President & CEO | Option Exercise | A | 2.24 | 600,000 | 1,344,000 | 600,000 | |
Jan 05 2018 | IDRA | IDERA PHARMACEUTIC ... | YINGLING JONATHAN MICHAEL | SVP, Early Developm ... | Option Exercise | A | 2.24 | 270,000 | 604,800 | 270,000 | |
Jan 05 2018 | IDRA | IDERA PHARMACEUTIC ... | Horobin Joanna | Chief Medical Offic ... | Option Exercise | A | 2.24 | 270,000 | 604,800 | 270,000 | |
Jan 05 2018 | IDRA | IDERA PHARMACEUTIC ... | Fletcher Robert C. | Sr. VP, Bus. Dev. & ... | Option Exercise | A | 2.24 | 270,000 | 604,800 | 270,000 | |
Jan 05 2018 | IDRA | IDERA PHARMACEUTIC ... | Arcudi III Louis J | Chief Financial Off ... | Option Exercise | A | 2.24 | 270,000 | 604,800 | 270,000 | |
Jan 05 2018 | IDRA | IDERA PHARMACEUTIC ... | Casey Mark J | Senior VP & General ... | Option Exercise | A | 2.24 | 270,000 | 604,800 | 270,000 | |
Jan 04 2018 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 2.21 | 9,333 | 20,626 | 163,831 | 154.5 K to 163.8 K (+6.04 %) |
Jan 04 2018 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 2.21 | 9,333 | 20,626 | 16,566,806 | 16.6 M to 16.6 M (+0.06 %) |
Jan 04 2018 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 2.21 | 9,333 | 20,626 | 1,851,950 | 1.8 M to 1.9 M (+0.51 %) |
Dec 15 2017 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | 10% Owner | Option Exercise | X | 0.47 | 700,000 | 329,000 | 0 | |
Dec 15 2017 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | 10% Owner | Sell | S | 1.91 | 33,830 | 64,527 | 0 | 33.8 K to 0 (-100.00 %) |
Dec 15 2017 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | 10% Owner | Sell | S | 2.00 | 300,000 | 599,430 | 0 | 300 K to 0 (-100.00 %) |
Dec 15 2017 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | 10% Owner | Sell | S | 2.00 | 700,000 | 1,400,000 | 0 | 700 K to 0 (-100.00 %) |
Dec 15 2017 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | 10% Owner | Buy | X | 0.00 | 700,000 | 0 | 0 | -700,000 to 0 (-100.00 %) |
Dec 15 2017 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | 10% Owner | Sell | S | 2.01 | 166,170 | 333,171 | 0 | 166.2 K to 0 (-100.00 %) |
Dec 15 2017 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | 10% Owner | Sell | S | 1.93 | 600,000 | 1,158,420 | 0 | 600 K to 0 (-100.00 %) |
Dec 15 2017 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | 10% Owner | Sell | S | 1.92 | 500,000 | 959,750 | 0 | 500 K to 0 (-100.00 %) |
Oct 30 2017 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 1.50 | 7,204,652 | 10,806,978 | 16,557,473 | 9.4 M to 16.6 M (+77.03 %) |
Oct 30 2017 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 1.50 | 795,348 | 1,193,022 | 1,842,617 | 1 M to 1.8 M (+75.94 %) |
Oct 17 2017 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | Director | Option Exercise | X | 0.70 | 6,842,844 | 4,789,991 | 0 | |
Oct 17 2017 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | Director | Buy | X | 0.00 | 6,842,844 | 0 | 0 | -6,842,844 to 0 (-100.00 %) |
Oct 04 2017 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 2.28 | 9,045 | 20,623 | 154,498 | 145.5 K to 154.5 K (+6.22 %) |
Oct 04 2017 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 2.28 | 9,045 | 20,623 | 9,352,821 | 9.3 M to 9.4 M (+0.10 %) |
Oct 04 2017 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 2.28 | 9,045 | 20,623 | 1,047,269 | 1 M to 1 M (+0.87 %) |
Oct 04 2017 | IDRA | IDERA PHARMACEUTIC ... | ZEIN YOUSSEF EL | Director | Grant | A | 2.28 | 4,721 | 10,764 | 534,980 | 530.3 K to 535 K (+0.89 %) |
Jul 07 2017 | IDRA | IDERA PHARMACEUTIC ... | ZEIN YOUSSEF EL | Director | Grant | A | 1.75 | 6,151 | 10,764 | 530,259 | 524.1 K to 530.3 K (+1.17 %) |
Jul 07 2017 | IDRA | IDERA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Grant | A | 1.75 | 7,714 | 13,500 | 32,973 | 25.3 K to 33 K (+30.54 %) |
Jul 06 2017 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 1.75 | 11,787 | 20,627 | 145,453 | 133.7 K to 145.5 K (+8.82 %) |
Jul 06 2017 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 1.75 | 11,787 | 20,627 | 9,343,776 | 9.3 M to 9.3 M (+0.13 %) |
Jul 06 2017 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 1.75 | 11,787 | 20,627 | 1,038,224 | 1 M to 1 M (+1.15 %) |
Jun 09 2017 | IDRA | IDERA PHARMACEUTIC ... | GERAGHTY JAMES A | Director | Option Exercise | A | 1.63 | 63,000 | 102,690 | 63,000 | |
Jun 09 2017 | IDRA | IDERA PHARMACEUTIC ... | Goldberg Mark Alan | Director | Option Exercise | A | 1.63 | 50,000 | 81,500 | 50,000 | |
Jun 09 2017 | IDRA | IDERA PHARMACEUTIC ... | GOWEN MAXINE | Director | Option Exercise | A | 1.63 | 50,000 | 81,500 | 50,000 | |
Jun 09 2017 | IDRA | IDERA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Option Exercise | A | 1.63 | 50,000 | 81,500 | 50,000 | |
Jun 09 2017 | IDRA | IDERA PHARMACEUTIC ... | ZEIN YOUSSEF EL | Director | Option Exercise | A | 1.63 | 50,000 | 81,500 | 50,000 | |
Jun 08 2017 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 1.63 | 100,000 | 163,000 | 100,000 | |
May 03 2017 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | Director | Option Exercise | X | 0.70 | 409,237 | 286,466 | 4,624,824 | |
May 03 2017 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | Director | Buy | X | 0.00 | 409,237 | 0 | 0 | -409,237 to 0 (-100.00 %) |
May 03 2017 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | Director | Sell | S | 2.26 | 409,237 | 924,507 | 0 | 409.2 K to 0 (-100.00 %) |
May 03 2017 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | Director | Sell | S | 2.26 | 41,578 | 93,929 | 0 | 41.6 K to 0 (-100.00 %) |
Apr 26 2017 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | Director | Sell | S | 2.29 | 890,593 | 2,037,944 | 0 | 890.6 K to 0 (-100.00 %) |
Apr 26 2017 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | Director | Sell | S | 2.29 | 437,829 | 1,002,059 | 0 | 437.8 K to 0 (-100.00 %) |
Apr 06 2017 | IDRA | IDERA PHARMACEUTIC ... | ZEIN YOUSSEF EL | Director | Grant | A | 2.43 | 4,430 | 10,765 | 528,538 | 524.1 K to 528.5 K (+0.85 %) |
Apr 05 2017 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 2.43 | 8,487 | 20,623 | 133,666 | 125.2 K to 133.7 K (+6.78 %) |
Apr 05 2017 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 2.43 | 8,487 | 20,623 | 9,331,989 | 9.3 M to 9.3 M (+0.09 %) |
Apr 05 2017 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 2.43 | 8,487 | 20,623 | 1,026,437 | 1 M to 1 M (+0.83 %) |
Feb 08 2017 | IDRA | IDERA PHARMACEUTIC ... | YINGLING JONATHAN MICHAEL | SVP of Early Develo ... | Option Exercise | A | 1.55 | 275,000 | 426,250 | 275,000 | |
Feb 08 2017 | IDRA | IDERA PHARMACEUTIC ... | YINGLING JONATHAN MICHAEL | SVP of Early Develo ... | Option Exercise | A | 1.55 | 325,000 | 503,750 | 325,000 | |
Jan 06 2017 | IDRA | IDERA PHARMACEUTIC ... | Fletcher Robert C. | Sr. VP, Bus. Dev. & ... | Option Exercise | A | 1.59 | 185,000 | 294,150 | 185,000 | |
Jan 06 2017 | IDRA | IDERA PHARMACEUTIC ... | Arcudi III Louis J | Chief Financial Off ... | Option Exercise | A | 1.59 | 185,000 | 294,150 | 185,000 | |
Jan 06 2017 | IDRA | IDERA PHARMACEUTIC ... | Casey Mark J | Senior VP & General ... | Option Exercise | A | 1.59 | 185,000 | 294,150 | 185,000 | |
Jan 06 2017 | IDRA | IDERA PHARMACEUTIC ... | Horobin Joanna | Chief Medical Offic ... | Option Exercise | A | 1.59 | 185,000 | 294,150 | 185,000 | |
Jan 06 2017 | IDRA | IDERA PHARMACEUTIC ... | MILANO VINCENT | President & CEO | Option Exercise | A | 1.59 | 300,000 | 477,000 | 300,000 | |
Jan 06 2017 | IDRA | IDERA PHARMACEUTIC ... | AGRAWAL SUDHIR | President of Resear ... | Option Exercise | A | 1.59 | 185,000 | 294,150 | 185,000 | |
Jan 05 2017 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Grant | A | 1.50 | 14,169 | 21,254 | 125,179 | 111 K to 125.2 K (+12.76 %) |
Jan 05 2017 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Grant | A | 1.50 | 14,169 | 21,254 | 9,323,502 | 9.3 M to 9.3 M (+0.15 %) |
Jan 05 2017 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Grant | A | 1.50 | 14,169 | 21,254 | 1,017,950 | 1 M to 1 M (+1.41 %) |
Jan 05 2017 | IDRA | IDERA PHARMACEUTIC ... | ZEIN YOUSSEF EL | Director | Grant | A | 1.50 | 7,216 | 10,824 | 524,108 | 516.9 K to 524.1 K (+1.40 %) |
Jan 05 2017 | IDRA | IDERA PHARMACEUTIC ... | GOWEN MAXINE | Director | Grant | A | 1.50 | 7,000 | 10,500 | 17,543 | 10.5 K to 17.5 K (+66.39 %) |
Nov 07 2016 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | Director | Option Exercise | X | 1.46 | 1,370,000 | 2,000,200 | 0 | |
Nov 07 2016 | IDRA | IDERA PHARMACEUTIC ... | Pillar Invest Corp | Director | Buy | X | 0.00 | 1,370,000 | 0 | 0 | -1,370,000 to 0 (-100.00 %) |
Oct 11 2016 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Buy | P | 2.00 | 2,928,596 | 5,857,192 | 9,309,333 | 6.4 M to 9.3 M (+45.90 %) |
Oct 11 2016 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Buy | P | 2.00 | 321,404 | 642,808 | 1,003,781 | 682.4 K to 1 M (+47.10 %) |
Oct 05 2016 | IDRA | IDERA PHARMACEUTIC ... | ZEIN YOUSSEF EL | Director | Buy | P | 2.56 | 4,228 | 10,824 | 516,892 | 512.7 K to 516.9 K (+0.82 %) |
Oct 05 2016 | IDRA | IDERA PHARMACEUTIC ... | GOWEN MAXINE | Director | Buy | P | 2.56 | 4,102 | 10,501 | 10,543 | 6.4 K to 10.5 K (+63.69 %) |
Oct 05 2016 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Grant | A | 2.56 | 8,299 | 21,245 | 111,010 | 102.7 K to 111 K (+8.08 %) |
Oct 05 2016 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Grant | A | 2.56 | 8,299 | 21,245 | 6,380,737 | 6.4 M to 6.4 M (+0.13 %) |
Oct 05 2016 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Grant | A | 2.56 | 8,299 | 21,245 | 682,377 | 674.1 K to 682.4 K (+1.23 %) |
Jul 06 2016 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Grant | A | 1.63 | 13,038 | 21,252 | 102,711 | 89.7 K to 102.7 K (+14.54 %) |
Jul 06 2016 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Grant | A | 1.63 | 13,038 | 21,252 | 6,372,438 | 6.4 M to 6.4 M (+0.21 %) |
Jul 06 2016 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Grant | A | 1.63 | 13,038 | 21,252 | 674,078 | 661 K to 674.1 K (+1.97 %) |
Jul 06 2016 | IDRA | IDERA PHARMACEUTIC ... | GERAGHTY JAMES A | Director | Grant | A | 1.63 | 9,720 | 15,844 | 435,369 | 425.6 K to 435.4 K (+2.28 %) |
Jul 06 2016 | IDRA | IDERA PHARMACEUTIC ... | ZEIN YOUSSEF EL | Director | Grant | A | 1.63 | 6,641 | 10,825 | 512,664 | 506 K to 512.7 K (+1.31 %) |
Jul 06 2016 | IDRA | IDERA PHARMACEUTIC ... | GOWEN MAXINE | Director | Grant | A | 1.63 | 6,441 | 10,499 | 6,441 | 0 to 6.4 K |
Jul 06 2016 | IDRA | IDERA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Grant | A | 1.63 | 4,102 | 6,686 | 25,259 | 21.2 K to 25.3 K (+19.39 %) |
Jun 15 2016 | IDRA | IDERA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Option Exercise | A | 1.44 | 35,000 | 50,400 | 35,000 | |
Jun 15 2016 | IDRA | IDERA PHARMACEUTIC ... | ZEIN YOUSSEF EL | Director | Option Exercise | A | 1.44 | 35,000 | 50,400 | 35,000 | |
Jun 15 2016 | IDRA | IDERA PHARMACEUTIC ... | Goldberg Mark Alan | Director | Option Exercise | A | 1.44 | 35,000 | 50,400 | 35,000 | |
Jun 15 2016 | IDRA | IDERA PHARMACEUTIC ... | GOWEN MAXINE | Director | Option Exercise | A | 1.44 | 35,000 | 50,400 | 35,000 | |
Jun 15 2016 | IDRA | IDERA PHARMACEUTIC ... | GERAGHTY JAMES A | Director | Option Exercise | A | 1.44 | 52,000 | 74,880 | 52,000 | |
Jun 15 2016 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Option Exercise | A | 1.44 | 70,000 | 100,800 | 70,000 | |
May 16 2016 | IDRA | IDERA PHARMACEUTIC ... | GERAGHTY JAMES A | Director | Buy | P | 1.34 | 10,000 | 13,400 | 425,649 | 415.6 K to 425.6 K (+2.41 %) |
May 13 2016 | IDRA | IDERA PHARMACEUTIC ... | Casey Mark J | Senior VP & General ... | Buy | P | 1.44 | 34,450 | 49,608 | 34,450 | 0 to 34.5 K |
Apr 05 2016 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Grant | A | 1.97 | 10,788 | 21,252 | 89,673 | 78.9 K to 89.7 K (+13.68 %) |
Apr 05 2016 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Grant | A | 1.97 | 10,788 | 21,252 | 6,359,400 | 6.3 M to 6.4 M (+0.17 %) |
Apr 05 2016 | IDRA | IDERA PHARMACEUTIC ... | BAKER JULIAN | Director | Grant | A | 1.97 | 10,788 | 21,252 | 661,040 | 650.3 K to 661 K (+1.66 %) |
Apr 05 2016 | IDRA | IDERA PHARMACEUTIC ... | ZEIN YOUSSEF EL | Director | Grant | A | 1.97 | 5,495 | 10,825 | 506,023 | 500.5 K to 506 K (+1.10 %) |
Mar 17 2016 | IDRA | IDERA PHARMACEUTIC ... | MILANO VINCENT | President & CEO | Buy | P | 1.97 | 40,000 | 78,800 | 246,527 | 206.5 K to 246.5 K (+19.37 %) |
Jan 08 2016 | IDRA | IDERA PHARMACEUTIC ... | AGRAWAL SUDHIR | President of Resear ... | Option Exercise | A | 2.88 | 231,250 | 666,000 | 231,250 | |
Jan 08 2016 | IDRA | IDERA PHARMACEUTIC ... | Arcudi III Louis J | Chief Financial Off ... | Option Exercise | A | 2.88 | 185,000 | 532,800 | 185,000 |